Dr Kavita Gandhi, MD, PHD - Medicare Emergency Medicine in San Francisco, CA

Dr Kavita Gandhi, MD, PHD is a medicare enrolled "Emergency Medicine" physician in San Francisco, California. She went to University Of Maryland School Of Medicine and graduated in 2013 and has 11 years of diverse experience with area of expertise as Emergency Medicine. She is a member of the group practice University Of California San Francisco and her current practice location is 1001 Portrero Ave, Room 1e21, Ucsf - Sfgh Department Of Emergency Medicine, San Francisco, California. You can reach out to her office (for appointments etc.) via phone at (415) 206-5752.

Dr Kavita Gandhi is licensed to practice in California (license number A144000) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1467895326.

Contact Information

Dr Kavita Gandhi, MD, PHD
1001 Portrero Ave, Room 1e21, Ucsf - Sfgh Department Of Emergency Medicine,
San Francisco, CA 94110
(415) 206-5752
Not Available



Physician's Profile

Full NameDr Kavita Gandhi
GenderFemale
SpecialityEmergency Medicine
Experience11 Years
Location1001 Portrero Ave, Room 1e21, San Francisco, California
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Kavita Gandhi attended and graduated from University Of Maryland School Of Medicine in 2013
  NPI Data:
  • NPI Number: 1467895326
  • Provider Enumeration Date: 04/10/2013
  • Last Update Date: 09/08/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 1658512256
  • Enrollment ID: I20160906002682

Medical Identifiers

Medical identifiers for Dr Kavita Gandhi such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1467895326NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine A144000 (California)Primary
390200000XStudent In An Organized Health Care Education/training Program (* (Not Available))Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Ucsf Medical CenterSan francisco, CAHospital
Zuckerberg San Francisco General Hosp & Trauma CtrSan francisco, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of California San Francisco44865672291298

News Archive

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

Morning sickness treatment still elusive: Review

According to experts we are nowhere near establishing safe and effective ways to treat morning sickness. Since the Thalidomide disaster in 1960's that led to severe birth defects in the infants, this area of research is scary and less explored by many researchers. Despite its name, the vomiting and nausea of morning sickness can occur at any time of the day and affect about half of pregnant women. Between 70% and 85% of women will experience nausea during pregnancy, with about half suffering vomiting. Around 2% will experience it so badly they need to be hospitalised.

Pharmacist-led HBPM program improves blood pressure control

A pharmacist-led home blood pressure monitoring program supported by the American Heart Association's Heart 360 website dramatically improved blood pressure control for patients with uncontrolled hypertension, according to a study.

No adverse side-effects have been observed in clinical trial of SARS vaccine

Sinovac Biotech has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with either SARS vaccine or placebo.

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Kavita Gandhi allows following entities to bill medicare on her behalf.
Entity NameUniversity Of California Sfgh Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366417420
PECOS PAC ID: 5496668410
Enrollment ID: O20031112000551

News Archive

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

Morning sickness treatment still elusive: Review

According to experts we are nowhere near establishing safe and effective ways to treat morning sickness. Since the Thalidomide disaster in 1960's that led to severe birth defects in the infants, this area of research is scary and less explored by many researchers. Despite its name, the vomiting and nausea of morning sickness can occur at any time of the day and affect about half of pregnant women. Between 70% and 85% of women will experience nausea during pregnancy, with about half suffering vomiting. Around 2% will experience it so badly they need to be hospitalised.

Pharmacist-led HBPM program improves blood pressure control

A pharmacist-led home blood pressure monitoring program supported by the American Heart Association's Heart 360 website dramatically improved blood pressure control for patients with uncontrolled hypertension, according to a study.

No adverse side-effects have been observed in clinical trial of SARS vaccine

Sinovac Biotech has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with either SARS vaccine or placebo.

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

Read more Medical News

› Verified 4 days ago

Entity NameUniversity Of California San Francisco
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1861578973
PECOS PAC ID: 4486567229
Enrollment ID: O20031212000897

News Archive

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

Morning sickness treatment still elusive: Review

According to experts we are nowhere near establishing safe and effective ways to treat morning sickness. Since the Thalidomide disaster in 1960's that led to severe birth defects in the infants, this area of research is scary and less explored by many researchers. Despite its name, the vomiting and nausea of morning sickness can occur at any time of the day and affect about half of pregnant women. Between 70% and 85% of women will experience nausea during pregnancy, with about half suffering vomiting. Around 2% will experience it so badly they need to be hospitalised.

Pharmacist-led HBPM program improves blood pressure control

A pharmacist-led home blood pressure monitoring program supported by the American Heart Association's Heart 360 website dramatically improved blood pressure control for patients with uncontrolled hypertension, according to a study.

No adverse side-effects have been observed in clinical trial of SARS vaccine

Sinovac Biotech has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with either SARS vaccine or placebo.

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

Read more Medical News

› Verified 4 days ago

Entity NameUcsf Medical Group Business Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477624104
PECOS PAC ID: 3779497870
Enrollment ID: O20040622001513

News Archive

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

Morning sickness treatment still elusive: Review

According to experts we are nowhere near establishing safe and effective ways to treat morning sickness. Since the Thalidomide disaster in 1960's that led to severe birth defects in the infants, this area of research is scary and less explored by many researchers. Despite its name, the vomiting and nausea of morning sickness can occur at any time of the day and affect about half of pregnant women. Between 70% and 85% of women will experience nausea during pregnancy, with about half suffering vomiting. Around 2% will experience it so badly they need to be hospitalised.

Pharmacist-led HBPM program improves blood pressure control

A pharmacist-led home blood pressure monitoring program supported by the American Heart Association's Heart 360 website dramatically improved blood pressure control for patients with uncontrolled hypertension, according to a study.

No adverse side-effects have been observed in clinical trial of SARS vaccine

Sinovac Biotech has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with either SARS vaccine or placebo.

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

Read more Medical News

› Verified 4 days ago

Entity NameSolano Gateway Medical Group, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952344293
PECOS PAC ID: 5496725418
Enrollment ID: O20040916001355

News Archive

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

Morning sickness treatment still elusive: Review

According to experts we are nowhere near establishing safe and effective ways to treat morning sickness. Since the Thalidomide disaster in 1960's that led to severe birth defects in the infants, this area of research is scary and less explored by many researchers. Despite its name, the vomiting and nausea of morning sickness can occur at any time of the day and affect about half of pregnant women. Between 70% and 85% of women will experience nausea during pregnancy, with about half suffering vomiting. Around 2% will experience it so badly they need to be hospitalised.

Pharmacist-led HBPM program improves blood pressure control

A pharmacist-led home blood pressure monitoring program supported by the American Heart Association's Heart 360 website dramatically improved blood pressure control for patients with uncontrolled hypertension, according to a study.

No adverse side-effects have been observed in clinical trial of SARS vaccine

Sinovac Biotech has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with either SARS vaccine or placebo.

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kavita Gandhi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Kavita Gandhi, MD, PHD
115 10th Ave,
San Francisco, CA 94118

Ph: (954) 895-9243
Dr Kavita Gandhi, MD, PHD
1001 Portrero Ave, Room 1e21, Ucsf - Sfgh Department Of Emergency Medicine,
San Francisco, CA 94110

Ph: (415) 206-5752

News Archive

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

Morning sickness treatment still elusive: Review

According to experts we are nowhere near establishing safe and effective ways to treat morning sickness. Since the Thalidomide disaster in 1960's that led to severe birth defects in the infants, this area of research is scary and less explored by many researchers. Despite its name, the vomiting and nausea of morning sickness can occur at any time of the day and affect about half of pregnant women. Between 70% and 85% of women will experience nausea during pregnancy, with about half suffering vomiting. Around 2% will experience it so badly they need to be hospitalised.

Pharmacist-led HBPM program improves blood pressure control

A pharmacist-led home blood pressure monitoring program supported by the American Heart Association's Heart 360 website dramatically improved blood pressure control for patients with uncontrolled hypertension, according to a study.

No adverse side-effects have been observed in clinical trial of SARS vaccine

Sinovac Biotech has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with either SARS vaccine or placebo.

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

Read more News

› Verified 4 days ago


Emergency Medicine Doctors in San Francisco, CA

Paul Robinson,
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1230 Arguello Blvd Apt 2, San Francisco, CA 94122
Phone: 415-948-8836    
Frederick D Pitts Jr., MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 229 7th St, San Francisco, CA 94103
Phone: 415-503-6042    Fax: 415-503-6099
Georgina Lisseth Calderon, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1501 10th Ave, Apt. 1, San Francisco, CA 94122
Phone: 323-514-0964    
Timothy Bauer Duncan, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 2333 Buchanan St, San Francisco, CA 94115
Phone: 209-342-2300    Fax: 209-524-4240
Bichhuong M Dinh, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3555 Cesar Chavez, San Francisco, CA 94110
Phone: 240-447-1281    
Dr. Lauren Elizabeth Chalwell, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1001 Potrero Avenue Department Of Emergency Medicine, San Francisco General Hospital,, San Francisco, CA 94110
Phone: 415-206-5753    
Dr. Jeremy Lacocque, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1001 Potrero Ave, San Francisco, CA 94110
Phone: 628-206-8000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.